AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Regulatory Filings Apr 24, 2018

5328_rns_2018-04-24_40744312-1bec-487d-b397-afb13074f829.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8430L

Spire Healthcare Group PLC

24 April 2018

Spire Healthcare Group plc

(the "Company")

Capital Markets Day

24 April 2018

Spire Healthcare Group plc (LSE: SPI), one of the UK's leading independent hospital groups, will today host a Capital Markets Day event for institutional investors and analysts. 

The event presentation materials will be available on the Company's website at 9.30am and the presentations will be audiocast live from that time at http://webcast.openbriefing.com/spire_cmd_2018/.

No unpublished price sensitive information will be disclosed at the meeting.

-Ends-

For further information please contact:

Spire Healthcare
Antony Mannion, Investor Relations Director +44 (0)20 7427 9160
Instinctif Partners
Damian Reece / Guy Scarborough / Alex Shaw +44 (0)20 7457 2020

[email protected]

About Spire Healthcare

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals, 11 clinics and one Specialist Cancer Care Centre across England, Wales and Scotland.

Spire Healthcare delivered tailored, personalised care to approximately 269,300 in-patients and daycase patients in 2017, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. Spire is uniquely positioned to capture a growing share of the rapidly expanding private healthcare market. The Group's well located and scalable hospitals have earned reputations as centres of excellence, delivering successful and award winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. Spire treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCEAKLDALAPEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.